Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion-Reference-Cited by-同舟云学术

Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion

Published:2010-03 Issue:3 Volume:25 Page:447-454
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Bertoldo Francesco,Pancheri Serena,Zenari Sonia,Boldini Stefania,Giovanazzi Benedetta,Zanatta Mirko,Valenti Maria Teresa,Carbonare Luca Dalle,Cascio Vincenzo Lo

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference56 articles.

1. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density;Saag;Bone.,2007

2. The acute phase response after bisphosphonates administration;Adami;Calcif Tissue Int.,1987

3. Adverse effect of bisphosphonates: a comparative review;Adami;Drug Saf.,1996

4. Safety considerations with bisphosphonates for the treatment of osteoporosis;Strampel;Drug Saf.,2007

5. Interleukin 6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen containing bisphosphonate dimethyl aminohydroxypropylidene bisphosphonate;Schweitzer;J Bone Miner Res.,1995

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of 2 Years of Monthly Calcifediol Administration in Postmenopausal Women with Vitamin D Insufficiency;Nutrients;2024-06-03

2. Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults;Nutrients;2024-01-16

3. Vitamin D and osteoporosis;Feldman and Pike's Vitamin D;2024

4. Prediction of musculoskeletal pain after the first intravenous zoledronic acid injection in patients with primary osteoporosis: development and evaluation of a new nomogram;BMC Musculoskeletal Disorders;2023-10-25

5. Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis;Frontiers in Pharmacology;2023-09-27